<VariationArchive VariationID="524023" VariationName="NM_000380.4(XPA):c.266_267dup (p.Val90fs)" VariationType="Duplication" Accession="VCV000524023" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2018-05-21" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="514600" VariationID="524023">
      <GeneList>
        <Gene Symbol="XPA" FullName="XPA, DNA damage recognition and repair factor" GeneID="7507" HGNC_ID="HGNC:12814" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="97654398" stop="97697340" display_start="97654398" display_stop="97697340" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="100437190" stop="100459690" display_start="100437190" display_stop="100459690" Strand="-" />
          </Location>
          <OMIM>611153</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000380.4(XPA):c.266_267dup (p.Val90fs)</Name>
      <CanonicalSPDI>NC_000009.12:97693664:TTTT:TTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="97693664" stop="97693665" display_start="97693664" display_stop="97693665" variantLength="2" positionVCF="97693664" referenceAlleleVCF="C" alternateAlleleVCF="CTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="100455946" stop="100455947" display_start="100455946" display_stop="100455947" variantLength="2" positionVCF="100455946" referenceAlleleVCF="C" alternateAlleleVCF="CTT" />
      </Location>
      <ProteinChange>V90fs</ProteinChange>
      <ProteinChange>V48fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_471" sequenceAccession="LRG_471">
            <Expression>LRG_471:g.8744_8745dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000380.3" sequenceAccession="NM_000380" sequenceVersion="3" change="c.266_267dupAA">
            <Expression>NM_000380.3:c.266_267dupAA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.100455949_100455950dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.100455949_100455950dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.97693667_97693668dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.97693667_97693668dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011642.1" sequenceAccession="NG_011642" sequenceVersion="1" change="g.8744_8745dup">
            <Expression>NG_011642.1:g.8744_8745dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000380.4" sequenceAccession="NM_000380" sequenceVersion="4" change="c.266_267dup" MANESelect="true">
            <Expression>NM_000380.4:c.266_267dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000371.1" sequenceAccession="NP_000371" sequenceVersion="1" change="p.Val90fs">
            <Expression>NP_000371.1:p.Val90fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354975.2" sequenceAccession="NM_001354975" sequenceVersion="2" change="c.140_141dup">
            <Expression>NM_001354975.2:c.140_141dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341904.1" sequenceAccession="NP_001341904" sequenceVersion="1" change="p.Val48fs">
            <Expression>NP_001341904.1:p.Val48fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027302.2" sequenceAccession="NR_027302" sequenceVersion="2" change="n.314_315dup">
            <Expression>NR_027302.2:n.314_315dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149091.2" sequenceAccession="NR_149091" sequenceVersion="2" change="n.314_315dup">
            <Expression>NR_149091.2:n.314_315dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149092.2" sequenceAccession="NR_149092" sequenceVersion="2" change="n.314_315dup">
            <Expression>NR_149092.2:n.314_315dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149093.2" sequenceAccession="NR_149093" sequenceVersion="2" change="n.314_315dup">
            <Expression>NR_149093.2:n.314_315dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149094.2" sequenceAccession="NR_149094" sequenceVersion="2" change="n.314_315dup">
            <Expression>NR_149094.2:n.314_315dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA5148874" DB="ClinGen" />
        <XRef Type="rs" ID="759052378" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000380.4(XPA):c.266_267dup (p.Val90fs) AND not provided" Accession="RCV000627517" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000380.4(XPA):c.266_267dup (p.Val90fs) AND Xeroderma pigmentosum group A" Accession="RCV003459478" Version="1">
        <ClassifiedConditionList TraitSetID="263">
          <ClassifiedCondition DB="MedGen" ID="C0268135">Xeroderma pigmentosum group A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-01" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-05-21" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27607234</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26743599</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="263" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9685" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum, complementation group A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, group A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum group A</ElementValue>
                <XRef ID="MONDO:0010210" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum, type 1</ElementValue>
                <XRef ID="Xeroderma+pigmentosum%2C+type+1/7566" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XPA</ElementValue>
                <XRef Type="MIM" ID="278700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XP1</ElementValue>
                <XRef Type="MIM" ID="278700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">XPA-Related Xeroderma Pigmentosum</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5624" />
                <XRef ID="5624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0268135" DB="MedGen" />
              <XRef ID="MONDO:0010210" DB="MONDO" />
              <XRef Type="MIM" ID="278700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1457231" SubmissionDate="2018-05-15" DateLastUpdated="2018-05-21" DateCreated="2018-05-21">
        <ClinVarSubmissionID localKey="GDX:2002466|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000748517" DateUpdated="2018-05-21" DateCreated="2018-05-21" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.266_267dupAA variant in the XPA gene has been reported previously as homozygous in multiple individuals with xeroderma pigmentosum, one of whom had a more severe phenotype including early skin cancer and intellectual disability (Lehmann et al., 2014; Fassihi et al., 2016). The c.266_267dupAA variant causes a frameshift starting with codon Valine 90, changes this amino acid to a Lysine residue, and creates a premature Stop codon at position 15 of the new reading frame, denoted p.Val90LysfsX15. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Although not observed as homozygous, the c.266_267dupAA variant is observed in 4/111566 (0.0036%) alleles from individuals of non-Finnish European background in large population cohorts (Lek et al., 2016). We interpret c.266_267dupAA as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000380.3:c.266_267dupAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4044226</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7855111" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000380.4:c.266_267dup|OMIM:278700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004206960" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000380.4:c.266_267dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="278700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4252604" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4881247|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002234885" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27607234</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26743599</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val90Lysfs*15) in the XPA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPA are known to be pathogenic (PMID: 27607234). This variant is present in population databases (rs759052378, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 26743599). ClinVar contains an entry for this variant (Variation ID: 524023). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XPA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.100455946_100455947insTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

